Katherine Davy

608 total citations
9 papers, 350 citations indexed

About

Katherine Davy is a scholar working on Rheumatology, Clinical Psychology and Experimental and Cognitive Psychology. According to data from OpenAlex, Katherine Davy has authored 9 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 3 papers in Clinical Psychology and 2 papers in Experimental and Cognitive Psychology. Recurrent topics in Katherine Davy's work include Rheumatoid Arthritis Research and Therapies (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Perfectionism, Procrastination, Anxiety Studies (2 papers). Katherine Davy is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Perfectionism, Procrastination, Anxiety Studies (2 papers). Katherine Davy collaborates with scholars based in United Kingdom, United States and Netherlands. Katherine Davy's co-authors include Michelle Gee, R.M.F. Berard, Murray B. Stein, Karen Dineen Wagner, Andrea Machin, David Carpenter, Ulla Lepola, Leslie Citrome, Thomas R. Thompson and Richard S.E. Keefe and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Journal of Clinical Psychiatry and Journal of Clinical Psychopharmacology.

In The Last Decade

Katherine Davy

8 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Katherine Davy United Kingdom	7	185	152	139	48	40	9	350
Ranganathan Ram United States	8	69 0.4×	237 1.6×	43 0.3×	17 0.4×	22 0.6×	10	348
Vincenza Spera Italy	10	43 0.2×	110 0.7×	39 0.3×	31 0.6×	41 1.0×	14	253
Anne Pankow Germany	10	35 0.2×	124 0.8×	54 0.4×	17 0.4×	26 0.7×	20	343
Bo Xiao China	13	132 0.7×	75 0.5×	17 0.1×	29 0.6×	9 0.2×	26	443
Max Baker United States	12	97 0.5×	134 0.9×	45 0.3×	80 1.7×	81 2.0×	12	415
Julia Perry United Kingdom	7	71 0.4×	81 0.5×	26 0.2×	19 0.4×	9 0.2×	9	266
M. Schwartz Israel	9	43 0.2×	70 0.5×	27 0.2×	9 0.2×	55 1.4×	16	267
Serkan Güneş Türkiye	10	49 0.3×	163 1.1×	37 0.3×	14 0.3×	5 0.1×	34	347
H Klar United States	9	224 1.2×	154 1.0×	29 0.2×	8 0.2×	10 0.3×	11	336
Hana Zouk Canada	6	142 0.8×	52 0.3×	14 0.1×	10 0.2×	10 0.3×	7	257

Countries citing papers authored by Katherine Davy

Since Specialization

Citations

This map shows the geographic impact of Katherine Davy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Davy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Davy more than expected).

Fields of papers citing papers by Katherine Davy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Davy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Davy. The network helps show where Katherine Davy may publish in the future.

Co-authorship network of co-authors of Katherine Davy

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Davy. A scholar is included among the top collaborators of Katherine Davy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Davy. Katherine Davy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Grenyer, Brin F. S., et al.. (2025). AIR therapy: a pilot study of a clinician-assisted e-therapy for adolescents with borderline personality disorder. Borderline Personality Disorder and Emotion Dysregulation. 12(1). 6–6.

Kalaitzaki, Eleftheria, Shuai Yuan, Alessandra Tosolini, et al.. (2023). Association of Minimal Residual Disease Negativity Rates With Progression Free Survival in Frontline Therapy Trials for Newly Diagnosed Multiple Myeloma: A Meta-analysis. Clinical Lymphoma Myeloma & Leukemia. 23(5). e213–e221. 9 indexed citations

Buckley, Christopher D., Jesus Abraham Simón Campos, Вячеслав Миколайович Ждан, et al.. (2020). Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study. The Lancet Rheumatology. 2(11). e677–e688. 24 indexed citations

Genovese, Mark C., Philip G. Conaghan, Charles Peterfy, et al.. (2020). MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study. The Lancet Rheumatology. 2(11). e666–e676. 15 indexed citations

Schett, Georg, L.C. Bainbridge, Katherine Davy, et al.. (2020). Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial. The Lancet Rheumatology. 2(10). e623–e632. 16 indexed citations

Buckley, Christopher D., Jesus Abraham Simón Campos, Вячеслав Миколайович Ждан, et al.. (2019). OP0228 GSK3196165 AN INVESTIGATIONAL ANTI-GM-CSF MONOCLONAL ANTIBODY, IMPROVES PATIENT REPORTED OUTCOMES IN A PHASE IIB STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS (RA). Annals of the Rheumatic Diseases. 78. 191–191. 4 indexed citations

Goff, Donald, Richard S.E. Keefe, Leslie Citrome, et al.. (2007). Lamotrigine as Add-On Therapy in Schizophrenia. Journal of Clinical Psychopharmacology. 27(6). 582–589. 78 indexed citations

Wagner, Karen Dineen, R.M.F. Berard, Murray B. Stein, et al.. (2004). A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial ofParoxetine in Children and Adolescents With Social Anxiety Disorder. Archives of General Psychiatry. 61(11). 1153–1153. 153 indexed citations

Lepola, Ulla, et al.. (2004). Controlled-Release Paroxetine in the Treatment of Patients With Social Anxiety Disorder. The Journal of Clinical Psychiatry. 65(2). 222–229. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact